Targeted therapies in lung cancer
- PMID: 17631566
- DOI: 10.1093/annonc/mdm308
Targeted therapies in lung cancer
Similar articles
-
Antiangiogenic agents.Suppl Tumori. 2002 Jul-Aug;1(4):S39-43. Suppl Tumori. 2002. PMID: 12415816 Review. No abstract available.
-
Multitargeted anti-angiogenic agents and NSCLC: clinical update and future directions.Crit Rev Oncol Hematol. 2012 Oct;84(1):47-58. doi: 10.1016/j.critrevonc.2012.02.004. Epub 2012 Mar 8. Crit Rev Oncol Hematol. 2012. PMID: 22405734 Review.
-
Nintedanib for the treatment of non-small-cell lung cancer.Expert Opin Pharmacother. 2014 Apr;15(5):729-39. doi: 10.1517/14656566.2014.897695. Epub 2014 Mar 5. Expert Opin Pharmacother. 2014. PMID: 24597846 Review.
-
[Angiogenesis and neoangiogenesis--the role in lung cancer and other tumors].Pneumonol Alergol Pol. 2006;74(4):414-20. Pneumonol Alergol Pol. 2006. PMID: 17427152 Review. Polish. No abstract available.
-
[Responses to targeted therapies: lung cancer].Ann Pathol. 2009 Nov;29 Spec No 1:S77-80. doi: 10.1016/j.annpat.2009.07.033. Epub 2009 Oct 8. Ann Pathol. 2009. PMID: 19887261 Review. French. No abstract available.
Cited by
-
FDG-PET/CT response evaluation during EGFR-TKI treatment in patients with NSCLC.World J Radiol. 2014 Jul 28;6(7):392-8. doi: 10.4329/wjr.v6.i7.392. World J Radiol. 2014. PMID: 25071879 Free PMC article. Review.
-
Identification of microRNA differentially expressed in three subtypes of non-small cell lung cancer and in silico functional analysis.Oncotarget. 2017 Aug 12;8(43):74554-74566. doi: 10.18632/oncotarget.20218. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088807 Free PMC article.
-
PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathway.J Cancer. 2021 Jun 11;12(16):4945-4957. doi: 10.7150/jca.53613. eCollection 2021. J Cancer. 2021. PMID: 34234864 Free PMC article.
-
Evaluation of PTEN and Mcl-1 expressions in NSCLC expressing wild-type or mutated EGFR.Med Oncol. 2010 Sep;27(3):853-60. doi: 10.1007/s12032-009-9296-7. Epub 2009 Sep 10. Med Oncol. 2010. PMID: 19763916
-
Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.Sci Rep. 2021 Mar 11;11(1):5679. doi: 10.1038/s41598-021-83646-7. Sci Rep. 2021. PMID: 33707479 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical